dc.contributor.author | Kaplan, C. | |
dc.contributor.author | Kocaman, Sinan Altan | |
dc.contributor.author | Durakoğlugil, Murtaza Emre | |
dc.contributor.author | Kaya, E. | |
dc.contributor.author | Şenol, M.G. | |
dc.date.accessioned | 2020-12-19T20:15:56Z | |
dc.date.available | 2020-12-19T20:15:56Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Kaplan, C., Kocaman, S. A., Durakoğlugil, M. E., Kaya, E., & Senol, M. G. (2013). Cardiac syncope due to pain: report of a case responsive to duloxetine treatment. Herz, 38(6), 683–684. https://doi.org/10.1007/s00059-012-3734-6 | en_US |
dc.identifier.issn | 0340-9937 | |
dc.identifier.uri | https://doi.org/10.1007/s00059-012-3734-6 | |
dc.identifier.uri | https://hdl.handle.net/11436/4088 | |
dc.description | PubMed: 23588599 | en_US |
dc.description.abstract | Neurocardiogenic syncope comprises situations triggered by neurological reflexes resulting in abnormal responses of the neurocardiovascular system that cause loss of consciousness. A vast number of clinical conditions may cause this disorder including pain, defecation, micturition, swallowing, cough, sudden fear or excitement, exercise, and long-time standing. Treatment options for syncope prevention are not satisfactory. Several agents were used for pharmacological treatment without success. Selective inhibitors of neuronal norepinephrine transporter (NET) like duloxetine may play a role in neurally mediated syncope by increasing synaptic norepinephrine levels. Therefore, we report the effect of duloxetine in a patient with pain-induced syncope resistant to standard regimens. © 2012 Urban & Vogel. Schlüsselwörter. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Springer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cardiac syncope | en_US |
dc.subject | Duloxetine | en_US |
dc.subject | Neurocardiovascular system | en_US |
dc.subject | Pain | en_US |
dc.subject | Treatment | en_US |
dc.title | Cardiac syncope due to pain: Report of a case responsive to duloxetine treatment | en_US |
dc.type | article | en_US |
dc.contributor.department | RTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.contributor.institutionauthor | Durakoğlugil, Murtaza Emre | |
dc.identifier.doi | 10.1007/s00059-012-3734-6 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | 683 | en_US |
dc.identifier.endpage | 684 | en_US |
dc.relation.journal | Herz | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |